Looking at the Influenza Virus Vaccine and SNG00124 Nov 2020 14:26
Did vaccines 'eradicate'flu? No, far from it. There are a number of strains and it constantly mutates. Thats why there has to be a different flu vaccine every year. Even then its only a scientific best guess if they've captured the dominant strain in the following season. Thats why we still get Flu PANDEMICS. Not only that but did you know the flu vaccine is only generally 40-50% effective...
SO, do we really believe it when we are told that in a matter of a few short months, tested on only a TINY TINY fraction of the worlds population that it is going to be 95% effective, or even 70% effective?
Onto treatments. So, because we have a Flu Vaccine I guess that means theres no need for a Flu treatment yes? NO. THere is a definite need for flu treatments and they are out there alright. Roche have Tamiflu and GSK have Relenza. And guess what, they sell in hundreds of millions, even billions in years when the Flu strain produces a pandemic type event (not rare).
Conclusion: there will absolutely be a need for SNG001 whether it arrives in Q1 or Q2 or Q3 next year. And quite realistically monthly sales could exceed the current market cap. eg.100,000 treatments x £3,000 per treatment = £300m pm.
Current MC £172m (which includes up to £87m cash from the placing to fund P3 trial)
The BIG mistake the market is currently making, and its a whopper, is that somehow SNG001 is in competition with Vaccines.
It 100% is NOT.